Literature DB >> 34107204

CROI 2021: Tuberculosis, Opportunistic Infections, and COVID-19 Among People with HIV.

Andrew D Kerkhoff1, Diane V Havlir1.   

Abstract

Tuberculosis (TB) remains a main driver of morbidity and mortality among people with HIV along with other opportunistic infections. This review summarizes key highlights related to TB, and other opportunistic infections in HIV as well as studies from the virtual 2021 Conference on Retroviruses and Oppoprtunitstic Infections evaluating outcomes among HIV-COVID-19 coinfected patients.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34107204      PMCID: PMC8224244     

Source DB:  PubMed          Journal:  Top Antivir Med        ISSN: 2161-5853


  2 in total

1.  Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.

Authors:  Francesca Conradie; Andreas H Diacon; Nosipho Ngubane; Pauline Howell; Daniel Everitt; Angela M Crook; Carl M Mendel; Erica Egizi; Joanna Moreira; Juliano Timm; Timothy D McHugh; Genevieve H Wills; Anna Bateson; Robert Hunt; Christo Van Niekerk; Mengchun Li; Morounfolu Olugbosi; Melvin Spigelman
Journal:  N Engl J Med       Date:  2020-03-05       Impact factor: 91.245

2.  One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.

Authors:  Susan Swindells; Ritesh Ramchandani; Amita Gupta; Constance A Benson; Jorge Leon-Cruz; Noluthando Mwelase; Marc A Jean Juste; Javier R Lama; Javier Valencia; Ayotunde Omoz-Oarhe; Khuanchai Supparatpinyo; Gaerolwe Masheto; Lerato Mohapi; Rodrigo O da Silva Escada; Sajeeda Mawlana; Peter Banda; Patrice Severe; James Hakim; Cecilia Kanyama; Deborah Langat; Laura Moran; Janet Andersen; Courtney V Fletcher; Eric Nuermberger; Richard E Chaisson
Journal:  N Engl J Med       Date:  2019-03-14       Impact factor: 91.245

  2 in total
  1 in total

1.  Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19.

Authors:  Silvia Bertagnolio; Soe Soe Thwin; Ronaldo Silva; Sairaman Nagarajan; Waasila Jassat; Robert Fowler; Rashan Haniffa; Ludovic Reveiz; Nathan Ford; Meg Doherty; Janet Diaz
Journal:  Lancet HIV       Date:  2022-05-10       Impact factor: 16.070

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.